Xiaozheng Kang

Washington University in St. Louis — United States

Medicine · Health Sciences

23h-index2.1kcitations153works5.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Esophageal Cancer Research and Treatment(57), Lung Cancer Treatments and Mutations(42), Gastric Cancer Management and Outcomes(37), Lung Cancer Diagnosis and Treatment(23), Cancer Genomics and Diagnostics(19)

Publications152 total

Trends in primary graft dysfunction and early mortality following lung transplantation: A single center experience
JHLT Open·2026Open Access
Senescence-driven molecular subtyping in pancreatic cancer: a multi-omics framework for precision medicine
BMC Cancer·2025Open Access
Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2)
Signal Transduction and Targeted Therapy·2025· 1 citedOpen Access
3D Structural Hijacking of Pathological α-Synuclein Fibrillar Architectures by Carbon Dot Nanoeraser Prevents Neurodegeneration
2025Open Access
Enhanced detection of HBV and HCV using Cas13a-FLAP and FGoAI platforms
Chemical Science·2025Open Access
Melatonin improves nutrient uptake and confers Cd tolerance in mung bean via Cd detoxification and redox regulation
Plant Physiology and Biochemistry·2025Open Access
Multifunctional Co-FeS2 nanozyme-hydrogel composite promotes diabetic wound healing by synergistic antioxidant, antibacterial, and anti-inflammation therapy
Journal of Colloid and Interface Science·2025· 1 cited
Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3)
BMJ Open·2025· 1 citedOpen Access
CRISPR/Cas13 system-based entropy-driven DNAzyme switch powered DNA walking system for sensitive and direct rotavirus detection
Microchimica Acta·2025
1495P Iparomlimab and tuvonralimab (QL1706) plus bevacizumab and/or chemotherapy in first-line treatment for advanced hepatocellular carcinoma: Updated data from the phase II part of DUBHE-H-308 study
Annals of Oncology·2025
2450P Phase I study of QLH12016, an androgen receptor (AR) PROTAC degrader in heavily pretreated patients with metastatic castration-resistant prostate cancer (mCRPC): safety, tolerability, and antitumor activity
Annals of Oncology·2025
448. EFFECTS OF DIFFERENT ANALGESIC MODALITIES ON PAIN RELIEF AND SAFETY AFTER MINIMALLY INVASIVE ESOPHAGECTOMY: A RANDOMIZED CONTROLLED CLINICAL STUDY
Diseases of the Esophagus·2025
349. PATHOLOGIC COMPLETE RESPONSE IN ESOPHAGEAL SQUAMOUS CELL CANCER: DO DIVERSE NEOADJUVANT MODALITIES PREDICT PROGNOSTIC DIFFERENCES?
Diseases of the Esophagus·2025
Dual blockade of TNFR2 and CD47 reshape tumor immune microenvironment and improve antitumor effects in colorectal cancer
Molecular Therapy·2025· 3 citedOpen Access
Orthostatic intolerance following posterior lumbar interbody fusion: incidence, risk factors, and impact on postoperative recovery: a prospective cohort study
The Spine Journal·2025
cfDNA hydroxymethylcytosine profiling for detection metastasis and recurrence of Esophageal Squamous Cell Carcinoma
World Journal of Surgical Oncology·2025· 2 citedOpen Access
In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors
Molecular Therapy·2025· 2 citedOpen Access
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma
Translational Oncology·2025· 2 citedOpen Access
Periarterial divestment following neoadjuvant therapy in patients with locally advanced pancreatic cancer with celiac axis invasion: A safe and effective surgical procedure
Surgery·2025· 2 cited
In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors
Molecular Therapy·2024· 3 cited
page 1 of 8Next →

Frequent Co-authors

Wanpu Yan(17), Ke‐Neng Chen(16), Jianjun Qin(8), Ruixiang Zhang(8), Zhen Wang(8), Ke‐Neng Chen(8), Xiankai Chen(7), Hongchao Xiong(7), Zhen Liang(7), Liang Dai(7), Liyan Xue(6), Liang Dai(6), Yongbo Yang(6), Yin Li(6), Jie He(5), Yong Li(5), Jianhao Lin(5), Luyan Shen(5), Bin Dong(5), Hao Fu(5)